Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair
Primary Purpose
Osteoarthritis
Status
Completed
Phase
Phase 1
Locations
Brazil
Study Type
Interventional
Intervention
Bone marrow aspiration
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring Cartilage injury, Osteoarthritis, Mesenchymal stem cells
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with mild to moderate osteoarthritis (visual analogue scale)
- History of joint swelling, pain, stiffness, altered gait and loss of motion due to degenerative cartilage
Exclusion Criteria:
- Any past history of neoplasia and primary hematological disease
- Autoimmune disease or the medical history
- Systemic bone or cartilage disorders
- Acute or chronic communicable diseases including Hepatitis B, Hepatitis C and HIV
- Co-morbidity which the physician deems as a contraindication to stem cell transplantation and bone marrow biopsy
- Evidence of infection or fractures in or around the joint
- Contraindication to bone marrow aspiration
- Deviation from the axial axis (varus or valgus) greater than 12 degrees.
Sites / Locations
- Centro de Tecnologia Celular, Pontifícia Universidade Católica do Paraná
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Mesenchymal stem cells
Arm Description
Bone marrow aspiration, Autologous bone marrow-derived mesenchymal stem cells
Outcomes
Primary Outcome Measures
Change in WOMAC (Western Ontario and McMaster Universities)score
Secondary Outcome Measures
Change from baseline in cartilage thickness at 6 months by MRI
Knee pain relief (WOMAC and Lequesne scores)
Change from baseline in progression of osteoarthritis at 12 months by plain radiograph (X-ray)
Full Information
NCT ID
NCT01895413
First Posted
July 1, 2013
Last Updated
December 11, 2017
Sponsor
Alexandra Cristina Senegaglia
Collaborators
Pontifícia Universidade Católica do Paraná, Consultório Médico Dr. Alcy Vilas Boas Jr., Paraná, Brasil, Hospital Marcelino Champagnat, Paraná, Brasil, Fundação Araucária
1. Study Identification
Unique Protocol Identification Number
NCT01895413
Brief Title
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair
Official Title
Autologous Bone Marrow-derived Mesenchymal Stem Cells Used in the Treatment of Articular Cartilage Injury
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
September 2012 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Alexandra Cristina Senegaglia
Collaborators
Pontifícia Universidade Católica do Paraná, Consultório Médico Dr. Alcy Vilas Boas Jr., Paraná, Brasil, Hospital Marcelino Champagnat, Paraná, Brasil, Fundação Araucária
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a non-randomized study aimed to determine the safety and efficacy of intra-articular injection of autologous bone marrow-derived mesenchymal stem cells in patients with knee articular cartilage defects.
Detailed Description
Osteoarthritis is the most prevalent joint disease, create articular cartilage defects is a frequent cause of joint pain, functional loss, and disability. Osteoarthritis often becomes chronic, and conventional treatments seek to ameliorate pain or improve mobility. However, these treatments rarely modify the course of the disease.Recent studies cell-based have shown encouraging results in both animal studies and a few human case reports. We designed a study to assess the safety and efficacy of osteoarthritis treatment with intra-articular injection of autologous bone marrow-derived mesenchymal stem cells.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
Cartilage injury, Osteoarthritis, Mesenchymal stem cells
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mesenchymal stem cells
Arm Type
Experimental
Arm Description
Bone marrow aspiration, Autologous bone marrow-derived mesenchymal stem cells
Intervention Type
Procedure
Intervention Name(s)
Bone marrow aspiration
Intervention Description
Single intra-articular injection of autologous bone marrow-derived mesenchymal stem cells by arthroscopy
Primary Outcome Measure Information:
Title
Change in WOMAC (Western Ontario and McMaster Universities)score
Time Frame
3 months, 6 months, 9 months, 12 months
Secondary Outcome Measure Information:
Title
Change from baseline in cartilage thickness at 6 months by MRI
Time Frame
6 months
Title
Knee pain relief (WOMAC and Lequesne scores)
Time Frame
3 months, 6 months, 12 months
Title
Change from baseline in progression of osteoarthritis at 12 months by plain radiograph (X-ray)
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosed with mild to moderate osteoarthritis (visual analogue scale)
History of joint swelling, pain, stiffness, altered gait and loss of motion due to degenerative cartilage
Exclusion Criteria:
Any past history of neoplasia and primary hematological disease
Autoimmune disease or the medical history
Systemic bone or cartilage disorders
Acute or chronic communicable diseases including Hepatitis B, Hepatitis C and HIV
Co-morbidity which the physician deems as a contraindication to stem cell transplantation and bone marrow biopsy
Evidence of infection or fractures in or around the joint
Contraindication to bone marrow aspiration
Deviation from the axial axis (varus or valgus) greater than 12 degrees.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paulo Brofman, PhD
Organizational Affiliation
Pontifícia Universidade Católica do Paraná
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centro de Tecnologia Celular, Pontifícia Universidade Católica do Paraná
City
Curitiba
State/Province
Paraná
ZIP/Postal Code
80215-901
Country
Brazil
12. IPD Sharing Statement
Learn more about this trial
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair
We'll reach out to this number within 24 hrs